Within a month or so, what may be the largest listing in stock market history is expected to list on the Nasdaq. Anthropic, the company behind the Claude family of AI models, is heading for public markets at a valuation up to US$2 trillion.
Inflation remains one of the more important investment inputs investors need to get their heads around. It truly influences what you should own if you’re aiming to outperform.
Inflation remains one of the more important investment inputs investors need to get their heads around. It truly influences what you should own if you’re aiming to outperform.
Electric vehicle stocks are experiencing a challenging start to the new year. Tesla's price cuts, higher-for-longer interest rates, and concerning economic data from China have dampened investor sentiment, casting a shadow over the once-bullish EV market.
Last year was another thematic-driven year with thematic ETFs gaining popularity among Australian investors. According to the 2023 ASX Investor Study, the proportion of Australian investors using ETFs has grown from 15% to 20% over the past three years.
PDD, the company behind the discount-retailing app Temu, recently surpassed Alibaba to become the most valuable e-commerce player in China. In November, the market capitalisation of this Nasdaq-listed start-up reached $US195.5 billion, surpassing Alibaba's $US182.6 billion.
Over the past year, PDD Holdings' stock has surged by over 70% to $US148 (as shown below), driven by robust growth in the domestic market coupled with aggressive expansion overseas, led by the US.
The buy now, pay later sector finds itself at the centre of a perfect storm, propelled by robust Black Friday/Cyber Monday sales and the deferred implementation of BNPL laws.
Services such as Affirm, Afterpay-owner Block, and Klarna played a pivotal role, facilitating a substantial $US7.3 billion in consumer spending during the recent five-day sale event in the US. Cyber Monday alone witnessed a remarkable 43% increase in BNPL purchases compared to the previous year, according to Adobe data.
In recent years, shorting stocks has become a common strategy for professional and individual investors alike, so there’s a growing population of investors on the lookout for stocks they believe will fall in value.
There has been considerable hype lately surrounding the weight-loss drugs Ozempic/Wegovy which was initially designed for managing diabetes.
From short sellers who believe Ozempic will disrupt competitors to endorsements by high-profile figures like Elon Musk and former UK Prime Minister Boris Johnson, these slimming drugs have transcended medical circles, shaking up entire industries from biotech and healthcare to fast food.
Recently, Microsoft and Google’s parent company Alphabet, two of the 'Magnificent Seven' tech companies, released their third-quarter earnings.
The results were initially well received with both companies exceeding the market’s revenue and earnings expectations.
Headlines about Elon Musk’s idiosyncratic behaviour have become inextricably connected with the public’s perception of electric vehicles (EVs).
Even after Tesla’s recent Q3 earnings call, some analysts were more concerned about Elon Musk’s off-topic remarks about everything ranging from the economy to weight loss than they were about the company’s numbers.
Strange times are afoot in financial markets with contradictory assumptions being priced into various asset classes. Here’s a great summary of the confusion investors must contend with at present…
In the words of Charlie Munger, <i>‘If you're not a little confused about what's going on, you don't understand it.’
The baby boomers have long been recognised as the wealthiest generation ever. But as per the famous expression, you can’t take it with you. With baby boomers’ ages ranging from fifty-nine to seventy-seven, there’s no escaping the fact we’re close to witnessing a passing of their wealth to the next generation.
Given the extent of this impending wealth transfer, the investment implications of this thematic are worth being aware of.
Most successful investors will testify to the fact that selecting outperforming stocks is as much about identifying high quality management teams as it is about analysing the numbers, arguably more so. With outperformance in mind, one of the leading indicators of a high quality management team is their ethics. It’s an area worthy of investor attention.
It won’t have escaped most investors’ attention that lithium continues to reign supreme as the market’s hottest commodity. Lithium stocks such as Pilbara Minerals (ASX:PLS) and Allkem (ASX:AKE) are once again amongst the strongest performers on the ASX year to date.
As with all investment themes, it’s worth delving deeper than the lithium headlines and associated stock outperformance to understand the longer term investment case.